China's Livzon Pharma to form JV with US biotech firm Cynvenio in China
Wednesday, May 20, 2015
* Says signs agreement to invest $9 million to subscribe to U.S. firm Cynvenio's series B preferred stock
* Says signs framework agreement with Cynvenio to firm a JV in China with registered capital 124 million yuan ($19.98 million)
reuters.com
